Partnering

Osteologix has a competitive intellectual property position and is looking for collaboration and partnership in further clinical areas to maximize commercial exploitation of its comprehensive patent portfolio. Osteologix focuses its internal development effort on its candidate drug programs in the areas of metabolic bone diseases and arthritis. The company is aggressively pursing these clinical programs using a lean and highly efficient internal organization.
Osteologix intends to progress these projects to late stage clinical development and then partner with international pharmaceutical companies for further development and commercialization.
In addition, Osteologix is looking to maximize value by exploring multiple therapeutic indications of its proprietary compound family.